Bio2Business is pleased to welcome IDT Biologika as Gold Sponsor at BOS Basel 2020.
IDT Biologika specializes in the contract development and manufacture of viral vaccines, gene and immunotherapeutics as well as sterile liquid and lyophilized biopharmaceuticals. We provide fully-integrated services for our customers, ranging from formulation development and clinical manufacturing through to large-scale production, packaging and quality control.
To find out more about IDT Biologika’s extensive services and capabilities, click here to visit our website. In addition click here for our press release of November 5th, 2019. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services, has awarded IDT Biologika a new Task Order to provide process development activities and production of a vaccine against the Respiratory Syncytial Virus (RSV).